Pediatr. pro Praxi, 2005; 6: 329-332

Onemocnění vyvolaná lidskými herpetickými viry

doc. MUDr. Dalibor Sedláček CSc1, MUDr. Jiří Dort2, MUDr. Věra ©truncová1, MUDr. Mirka ©vecová3
1 Infekční klinika FN a LF UK, Plzeň
2 Neonatologické oddělení, FN a LF UK, Plzeň
3 Virologické oddělení, FN a LF UK Plzeň

Humánní herpetické viry (HHV) patří do čeledi Herpesviridae (tab. 1). Jedná se o poměrně velké DNA viry (s průměrem kolem 200 nm) s kubickou symetrií virové kapsidy. HHV jsou ubikviterní, jejich hostitelem je člověk. Přenos HHV se uskutečňuje slinami, genitálními sekrety, krví a vertikálně. Vstupní bránou můľe být respirační trakt, poruąená kůľe, sliznice genitálu, jindy mohou HHV do makroorganizmu proniknout intravenózní cestou, transplantovaným orgánem či kostní dření nebo transplacentárně. Dosud bylo objeveno a popsáno celkem 8 HHV, které se označují jako HHV1 aľ HHV8. HHV jsou vąak v praxi označovány zpravidla zkratkou odvozenou z názvu viru. Genomy některých HHV jsou schematicky uvedeny na obr. 1....

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sedláček D, Dort J, ©truncová V, ©vecová M. Onemocnění vyvolaná lidskými herpetickými viry. Pediatr. praxi. 2005;6(6):329-332.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ablashi DV, Josephs SF, Buchbinder A, et al. Human B-lymphotropic virus (human herpesvirus-6). J. Virol. Methods. 1988; 21: 29-48. Go to original source... Go to PubMed...
    2. Anonymous. Herpesviruses. http://www-micro.msb.le.ac.uk/3035/Herpesviruses.html.
    3. Bartoąová D, Klapačová L, Kunická J. Klinická manifestace herpesvirových onemocnění. Část 1. Infekce vyvolané viry herpes simplex a varicella-zoster. Čs. Pediat. 1997; 52(9): 700-703.
    4. Caserta MT, Mock DJ, Dewhurst S. Human Herpesvirus 6. Clinical Infectious Diseases. 2001; 33: 1-5. Go to original source... Go to PubMed...
    5. Cohen JI, Brunell PA, Strauss SE, Krause PR. Recent Advances in Varicella-Zoster Virus Infection. Ann Intern Med. 1999; 130: 922-932. Go to original source... Go to PubMed...
    6. Emery VC, et al. Interactions between B-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus six. J Med Virol. 1999; 57: 278-282. Go to original source... Go to PubMed...
    7. Fafi-Kremer S, et al. Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis. 2005; 191: 985-989. Go to original source... Go to PubMed...
    8. Ganz NM, Brown RB, Berk SL, et al. Manual of Clinical Problems in Infectious Disease. 4th Ed. Philadelphia: Lippincott Williams & Wilkins. 1999: 151-185.
    9. Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus Dermatol Clin. 2003; 21(2): 311-320. Go to original source... Go to PubMed...
    10. Jenson HB. Human Herpesvirus 8 infection. Current Opinions in Pediatrics. 2003; 15: 85-91. Go to original source... Go to PubMed...
    11. Liesgang TJ. Varicella Zoster Viral Disease. Mayo Clin Proc. 1999; 74: 983-998. Go to original source...
    12. Lowance D, Neumayer HH, Legendre CM, et al. Valcyclovir for the prevention of cytomegalovirus disease after renal transplantation. NEJM. 1999;340:1462-1470. Go to original source... Go to PubMed...
    13. Mandell GL, Benett JE, Dolin R. Principles and Practice of Infectious Diseases. 6th Ed. New York: Churchill Livingstone. 2004. On line.
    14. Mendez JC, Dockrell DH, Espy MJ, et al. Human Beta-Herpesvirus Interactions in Solid Organ Transplant Recipients. Journal of Infectious Diseases. 2001; 183:1 79-184. Go to original source... Go to PubMed...
    15. Razonable RR, Paya CV. The Impact of Human Herpesvirus-6 and -7 Infection on the Outcome of Liver Transplantation. Liver Transplantation. 2002; 8: 651-658. Go to original source... Go to PubMed...
    16. SPC jednotlivých léčivých přípravků a vakcín.
    17. Stebbing J, Portsmouth S, Gotch F, Gazzard B. Kaposi's sarcoma-an update. International Journal of STD & AIDS. 2003; 14: 225-227. Go to original source... Go to PubMed...
    18. van Esser JWJ, van der Holt B, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogenic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell depleted SCT. Blood. 2001; 98: 972-978. Go to original source... Go to PubMed...
    19. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001; 357: 1513-1518. Go to original source... Go to PubMed...
    20. Wilks D, Farrington M, Rubenstein D. The Infectious Diseases Manual. 2nd Ed. Oxford: Blackwell Publishing 2003: 96-103. Go to original source...
    21. Wilson WR, Sande MA. Current Diagnosis & Treatment in Infectious Diseases. New York: Lange / Mc Graw-Hill 2001: 65-84.
    22. http://www.fact-sheets.com/health/herpes_symptoms_treatment/
    23. http://www.herpes.org.uk/
    24. http://www.herpes.com/
    25. http://www.genitalherpes.com/index.jsp
    26. http://www.virology.net/Big_Virology/BVDNAherpes.html
    27. http://www.emedicine.com/EMERG/topic247.htm
    28. http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm
    29. http://www.herpesdiagnosis.com/index.html

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.